Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.

Aged Aged, 80 and over Antigens, CD / metabolism Biomarkers / metabolism Bone Marrow / metabolism Dendritic Cells / metabolism Female Humans Leukemia, Myelomonocytic, Chronic / metabolism Male Membrane Proteins / metabolism Prognosis T-Lymphocytes, Regulatory / metabolism

Journal

Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895

Informations de publication

Date de publication:
10 2019
Historique:
received: 10 11 2018
accepted: 11 03 2019
revised: 13 02 2019
pubmed: 22 3 2019
medline: 6 2 2020
entrez: 22 3 2019
Statut: ppublish

Résumé

Islands of CD123

Identifiants

DOI: 10.1038/s41375-019-0447-3 PMID: 30894665
pubmed: 30894665
doi: 10.1038/s41375-019-0447-3
pii: 10.1038/s41375-019-0447-3
doi:

Substances chimiques

Antigens, CD 0
Biomarkers 0
Membrane Proteins 0
flt3 ligand protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2466-2480

Auteurs

Nolwenn Lucas (N)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France.
Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.

Matthieu Duchmann (M)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
ORCID: 0000-0002-7299-4572

Philippe Rameau (P)

INSERM US23, CNRS UMS3655 Gustave Roussy Cancer Center, Villejuif, France.

Floriane Noël (F)

INSERM U932, Institut Curie, PSL Research University, Paris, France.

Paula Michea (P)

INSERM U932, Institut Curie, PSL Research University, Paris, France.

Véronique Saada (V)

Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.
ORCID: 0000-0001-8021-9050

Olivier Kosmider (O)

Inserm U1016, CNRS UMR8104, Institut Cochin, Université Paris Descartes, Paris, France.
Hôpital Cochin, Service d'hématologie biologique, Paris, France.

Gérard Pierron (G)

INSERM US23, CNRS UMS3655 Gustave Roussy Cancer Center, Villejuif, France.

Martin E Fernandez-Zapico (ME)

Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Matthew T Howard (MT)

Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Rebecca L King (RL)

Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.

Sandrine Niyongere (S)

Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

M'boyba Khadija Diop (MK)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
INSERM US23, CNRS UMS3655 Gustave Roussy Cancer Center, Villejuif, France.
ORCID: 0000-0002-7849-4405

Pierre Fenaux (P)

Department of Hematology, Hopital Saint Louis, Universite Paris Diderot, Paris, France.

Raphael Itzykson (R)

Department of Hematology, Hopital Saint Louis, Universite Paris Diderot, Paris, France.

Christophe Willekens (C)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.

Vincent Ribrag (V)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.

Michaela Fontenay (M)

Inserm U1016, CNRS UMR8104, Institut Cochin, Université Paris Descartes, Paris, France.
Hôpital Cochin, Service d'hématologie biologique, Paris, France.
ORCID: 0000-0002-5492-6349

Eric Padron (E)

Malignant Hematology Department, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

Vassili Soumelis (V)

INSERM U932, Institut Curie, PSL Research University, Paris, France.

Nathalie Droin (N)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.
INSERM US23, CNRS UMS3655 Gustave Roussy Cancer Center, Villejuif, France.
ORCID: 0000-0002-6099-5324

Mrinal M Patnaik (MM)

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Patnaik.Mrinal@mayo.edu.
ORCID: 0000-0001-6998-662X

Eric Solary (E)

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France. eric.solary@gustaveroussy.fr.
Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France. eric.solary@gustaveroussy.fr.
Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France. eric.solary@gustaveroussy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Biology and prognostic impact of clonal...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Biology and prognostic impact of clonal...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Antigènes de différenciation › Antigènes CD › Biology and prognostic impact of clonal...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Biology and prognostic impact of clonal...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Moelle osseuse › Biology and prognostic impact of clonal...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Système phagocytaire mononucléé › Cellules dendritiques › Biology and prognostic impact of clonal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Biology and prognostic impact of clonal...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Leucémie myélomonocytaire chronique › Biology and prognostic impact of clonal...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Biology and prognostic impact of clonal...
questionsmedicales.fr › Diagnostic › Pronostic › Biology and prognostic impact of clonal...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Sous-populations de lymphocytes T › Lymphocytes T régulateurs › Biology and prognostic impact of clonal...